Clinical Trial Update: Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating hippocampal-sparing prophylactic cranial irradiation in patients with pathologically nodal positive non-small-cell lung cancer and br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis | Phase 2, Phase 3 | Status: RECRUITING